Cargando…

Unexpected curative effect of PD-1 inhibitor in gastric cancer with brain metastasis: A case report

BACKGROUND: Gastric cancer (GC) is the third most common cause of cancer-related death in the world. Several clinical trials have proven that the use of PD-1/PD-L1 inhibitors can improve the survival of late-stage GC patients and is suggested in NCCN and CSCO guidelines. However, the correlation bet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qijun, Shen, Zhewei, Ge, Mengxi, Xu, Jie, Zhang, Xin, Zhu, Wei, Liu, Jie, Hua, Wei, Mao, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978328/ https://www.ncbi.nlm.nih.gov/pubmed/36874117 http://dx.doi.org/10.3389/fonc.2023.1042417

Ejemplares similares

The Combination Options and Predictive Biomarkers of PD-1/PD-L1 Inhibitors in Esophageal Cancer
por: Yang, Hui, et al.
Publicado: (2020)

Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitors Plus Lenvatinib Versus PD-1 Inhibitors Plus Lenvatinib for Advanced Hepatocellular Carcinoma
por: Mei, Jie, et al.
Publicado: (2021)

Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer
por: Mao, Deli, et al.
Publicado: (2021)

Towards Personalization in the Curative Treatment of Gastric Cancer
por: Slagter, Astrid E., et al.
Publicado: (2020)

Immune checkpoint inhibitors for PD-1/PD-L1 axis in combination with other immunotherapies and targeted therapies for non-small cell lung cancer
por: Mussafi, Ofek, et al.
Publicado: (2022)

Case report: PD-1 inhibitor-based treatment strategies in gastric cancer complicated by bone marrow metastasis and disseminated intravascular coagulation: A report of two cases
por: Huang, Ren-Ze, et al.
Publicado: (2023)

Unexpected endometrial metastasis of a primary lung adenocarcinoma
por: Patel, Visad, et al.
Publicado: (2018)

Systemic treatments for breast cancer brain metastasis
por: Chen, Qiuchi, et al.
Publicado: (2023)

Case report: Significant response to PD-L1 inhibitor after resistance to PD-1 inhibitor in an advanced alpha-fetoprotein-positive gastric cancer
por: Wang, Liyu, et al.
Publicado: (2022)

G6PD-NF-κB-HGF Signal in Gastric Cancer-Associated Mesenchymal Stem Cells Promotes the Proliferation and Metastasis of Gastric Cancer Cells by Upregulating the Expression of HK2
por: Chen, Bin, et al.
Publicado: (2021)

Combining neoadjuvant chemotherapy with PD-1/PD-L1 inhibitors for locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis
por: Yuan, Zhen, et al.
Publicado: (2023)

Comparative Safety of PD-1/PD-L1 Inhibitors for Cancer Patients: Systematic Review and Network Meta-Analysis
por: Huang, Ya-fang, et al.
Publicado: (2019)

Clinical outcomes and risk factors of non-curative endoscopic submucosal dissection for early gastric cancer: a retrospective multicenter study in Zhejiang, China
por: Jin, Chao-qiong, et al.
Publicado: (2023)

Overcoming resistance to PD-1/PD-L1 inhibitors in esophageal cancer
por: Cheng, Chao, et al.
Publicado: (2022)

Efficacy and safety of PD-1/PD-L1 inhibitor combined with chemotherapy versus chemotherapy alone in the treatment of advanced gastric or gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis
por: Liu, Bo-Wei, et al.
Publicado: (2023)

Diffuse Reduction of Spleen Density Is an Independent Predictor of Post-Operative Outcomes After Curative Gastrectomy in Gastric Cancer: A Multi-Center Study
por: Huang, Yun-Shi, et al.
Publicado: (2020)

PD-1 inhibitors plus lenvatinib versus PD-1 inhibitors plus regorafenib in patients with advanced hepatocellular carcinoma after failure of sorafenib
por: Xu, Yongkang, et al.
Publicado: (2022)

Canagliflozin, characterized as a HDAC6 inhibitor, inhibits gastric cancer metastasis
por: Jiang, Dandan, et al.
Publicado: (2022)

Efficacy and Safety of Fruquintinib Plus PD-1 Inhibitors Versus Regorafenib Plus PD-1 Inhibitors in Refractory Microsatellite Stable Metastatic Colorectal Cancer
por: Sun, Liying, et al.
Publicado: (2021)

Body Mass Index and Prognosis of Patients With Stage II/III Gastric Cancer After Curative Gastrectomy: Completion of Perioperative Adjuvant Chemotherapy May Be a Confounding Factor
por: Peng, Wei, et al.
Publicado: (2022)

Non-coding RNAs as Regulators of Lymphangiogenesis in Lymphatic Development, Inflammation, and Cancer Metastasis
por: Cao, Ming-xin, et al.
Publicado: (2019)

Case Report: a rare primary gastric choriocarcinoma revealed on (18)F-FDG PET/CT
por: Zhao, Yi, et al.
Publicado: (2023)

Survival Benefits of Anti-PD-1 Therapy in Combination With Radiotherapy in Chinese Melanoma Patients With Brain Metastasis
por: Wu, Shuang, et al.
Publicado: (2021)

Nomograms for Predicting the Lymph Node Metastasis in Early Gastric Cancer by Gender: A Retrospective Multicentric Study
por: Sui, Wannian, et al.
Publicado: (2021)

Analysis of the Curative Effect of Neoadjuvant Therapy on Pancreatic Cancer
por: Yang, Liqiong, et al.
Publicado: (2021)

Detection of asymptomatic recurrence following curative surgery improves survival in patients with gastric cancer: A systematic review and meta-analysis
por: Pang, Hua-Yang, et al.
Publicado: (2022)

Meta-Analysis of Efficacy From CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients
por: Xu, Li, et al.
Publicado: (2022)

Extracellular Vesicles From Gastric Cancer Cells Induce PD-L1 Expression on Neutrophils to Suppress T-Cell Immunity
por: Shi, Yinghong, et al.
Publicado: (2020)

Risk Factors and Outcomes of Early Relapse After Curative Resection of Intrahepatic Cholangiocarcinoma
por: Yang, Hua, et al.
Publicado: (2019)

Development and validation of prognostic dynamic nomograms for hepatitis B Virus-related hepatocellular carcinoma with microvascular invasion after curative resection
por: Bai, Shilei, et al.
Publicado: (2023)

FYN promotes gastric cancer metastasis by activating STAT3-mediated epithelial-mesenchymal transition
por: Yu, Jie, et al.
Publicado: (2020)

Prognostic influence of PD-1/PD-L1 suppressors in combination with chemotherapeutic agents for non-small cell pulmonary carcinoma: system review and meta-analysis
por: Shen, Min, et al.
Publicado: (2023)

Liver metastasis affects progression pattern during immune checkpoint inhibitors monotherapy in gastric cancer
por: Motoo, Iori, et al.
Publicado: (2023)

Upregulation of XIAP promotes lung adenocarcinoma brain metastasis by modulating ceRNA network
por: Wang, Yingjing, et al.
Publicado: (2022)

Intrahepatic cholangiocarcinoma with gastric metastasis misdiagnosed as primary gastric cancer: A case report and literature review
por: Zhu, Qingshun, et al.
Publicado: (2022)

Apatinib combined with PD-1 antibody for third-line or later treatment of advanced gastric cancer
por: Cui, Qingli, et al.
Publicado: (2022)

Positive Phospho-Focal Adhesion Kinase in Gastric Cancer Associates With Poor Prognosis After Curative Resection
por: Peng, Ke, et al.
Publicado: (2022)

Hepatic arterial infusion chemotherapy combined with PD-1 inhibitors and tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: A tertiary medical center experience
por: Luo, Laihui, et al.
Publicado: (2022)

Comprehensive Roles and Future Perspectives of Exosomes in Peritoneal Metastasis of Gastric Cancer
por: Chen, Xiangliu, et al.
Publicado: (2021)

The Research Progress of PD-1/PD-L1 Inhibitors Enhancing Radiotherapy Efficacy
por: Wen, Lu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5cud2qiboee3q7tj6jp833hcs7